7
Summary
Essential Thrombocythemia AK
Preface
1
Introduction
2
Risk stratification in ET
3
Clinical Guidelines for Peg-IFN-α Usage in Practice
4
INCA33989 Phase 1 Clinical Trial Results in Essential Thrombocythemia - ASH 2025 Update
5
INCA035784 A Novel T Cell-Redirecting Antibody for mutCALR MPN
6
Novel Therapies in ET
7
Summary
References
7
Summary
In summary, this book has no content whatsoever.
1
+
1
[1] 2
6
Novel Therapies in ET
References